Abstract

Topical Treatment of Primary Focal Hyperhidrosis, Part 1

Author(s): Zur Eyal

Issue: Jan/Feb 2019 - Volume 23, Number 1

Page(s): 23-31

Download in electronic PDF format for $75

Abstract

Primary focal hyperhidrosis is idiopathic, localized, uncontrollable, excessive, and unpredictable sweating beyond what is necessary to regulate body temperature. Primary hyperhidrosis is thought to affect approximately 2% to 3% of the population, and its effect on a patient's quality of life is very significant. Primary focal hyperhidrosis can be managed using various therapeutic options, including drugs (topical and systemic), nonsurgical interventions (e.g., iontophoresis, botulinum toxin injections), and surgery. This article, which is presented in 2 parts, is a comprehensive review of the topical, evidence-based treatments of primary focal hyperhidrosis, and it covers the following active pharmaceutical ingredients: aluminum salts, methenamine, glycopyrronium salts, oxybutynin chloride; the latter 2 ingredients will be discussed in part 2 of this article. This article discusses the evidence-based data that exists from clinical trials that support the use of topical medications to treat the pathology from efficacy and from a safety point of view. This review also discusses compounding considerations for professionally and safely compounding various topical preparations. In addition, a range of relevant formulas are attached to the article and can be used by compounding pharmacists.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Mar/Apr 2019 Pg. 94-104	Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Author(s): Zur Eyal
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
Nov/Dec 2020 Pg. 451-458	Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Jan/Feb 2001 Pg. 28-29	Topical Therapy for Localized Hyperhidrosis Author(s): Glasnapp Andrew
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Jan/Feb 2017 Pg. 22-27	Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Jul/Aug 2019 Pg. 351	Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104. Author(s):
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Jul/Aug 2002 Pg. 288-292	Basics of Compounding for Iontophoresis, Part II Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 270-274	A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Author(s): Riepl Mike
Nov/Dec 2022 Pg. 480-488	A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Author(s): Riepl Mike
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2012 Pg. 462-469	Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents Author(s): Zur Eyal
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
May/Jun 2017 Pg. 205-211	Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea